First Eagle Investment Management
ATRC icon

First Eagle Investment Management’s AtriCure ATRC Stock Holding History

First Eagle Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.33M Buy
297,643
+35,500
+14% +$999K 0.01% 268
2026
Q1 		$7.48M Buy
262,143
+145,534
+125% +$4.97M 0.01% 230
2025
Q4 		$4.61M Buy
+116,609
New +$4.27M 0.01% 265

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

First Eagle Investment Management's ATRC Position: Q2 2026 in Review

First Eagle Investment Management increased its AtriCure (ATRC) stake by 14% in Q2 2026, buying an estimated $999K and bringing the position to 297,643 shares worth $8.33M. The position accounts for 0.01% of the portfolio, ranked #268.

First Eagle Investment Management first reported a position in ATRC in Q4 2025 and has held it in 3 quarters since. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • First Eagle Investment Management held 297,643 shares of AtriCure worth $8.33M as of Q2 2026.
  • First Eagle Investment Management bought 35,500 AtriCure shares in Q2 2026, an estimated $999K.
  • AtriCure made up 0.01% of First Eagle Investment Management's portfolio in Q2 2026, its #268 holding.
  • First Eagle Investment Management first reported a position in AtriCure in Q4 2025 and has held it in 3 quarters since.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on First Eagle Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.